PaloDEx signs Definitive Agreement to Join Gendex, DEXIS and ISI

PaloDEx signs Definitive Agreement to Join Gendex, DEXIS and ISI

October 12, 2009 – Danaher Corporation today announced that it has entered into a definitive agreement to acquire PaloDEx Holding Oy (“PaloDEx”), a leading manufacturer of dental imaging products with revenues of more than $100M that goes to market under the Instrumentarium Dental and SOREDEX brands. The transaction is subject to regulatory approval and customary closing conditions.Instrumentarium Dental and SOREDEX will join Gendex, DEXIS, ISI, KaVo and Pelton & Crane as part of Danaher’s group of market-leading dental equipment companies.

Instrumentarium Dental and SOREDEX and their products have been highly regarded by dental professionals since their inception 45 years ago. PaloDEx’s product range includes 3D CBCT, Panoramic x-ray (including the OP200), PSP (including the Optime IO PSP) and other intra-oral and extra-oral xray imaging systems.

“We believe this acquisition will be a game-changer for both of our companies and we are excited about the opportunity to acquire two of the leading imaging brands. Instrumentarium Dental and Soredex’s excellent digital imaging products and technology will be a great fit with our existing Gendex, DEXIS and i-CAT business. PaloDEx has a very experienced team and we look forward to working with Henrik Roos, President of PaloDEx, and his team as we continue to build the business,” said Henk van Duijnhoven, Group Executive of Danaher’s KaVo Group.

Henrik Roos will remain in his position and added: “I am thrilled to join Danaher’s dental business. The combined business will create a unique opportunity to provide new and innovative technologies in digital dentistry with focus on diagnostics and treatment planning for general practitioners and specialists.”

Statements in this document that are not strictly historical, including statements regarding the proposed acquisition, future financial and operating results, benefits and synergies of the transaction, future opportunities for the combined company and any other statements about managements’ future expectations, beliefs, goals, plans or prospects, may constitute forward looking statements. These are a number of important factors that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements. These factors include, among other things: general economic conditions and conditions affecting the dental equipment industry; the uncertainty of regulatory approvals; the parties’ ability to satisfy the closing conditions and consummate the transactions; Danaher’s ability to successfully integrate the Palodex business with Danaher’s existing businesses; and the ability to realize anticipated growth, synergies and cost savings. Additional information regarding factors that may cause actual results to differ materially from these forward-looking statements is available in Danaher’s SEC filings, including Danaher’s 2008 Annual Report on Form 10-K and Quarterly Report on Form 10-Q for the quarter ended July 3, 2009. These forward-looking statements speak only as of the date of this release and Danaher does not assume any obligation to update any forward-looking statement.